Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Sherwood-Davis & Geck/Mead Johnson Nutritionals

This article was originally published in The Gray Sheet

Executive Summary

Sherwood-Davis & Geck/Mead Johnson Nutritionals: Companies enter agreement to co-market enteral nutritional formula products and devices in the U.S. Under the pact, American Home Products division Sherwood-Davis & Geck will serve as the sales agent for Mead Johnson's line of medical nutritionals -- including the Sustacal, Isocal, and Ultracal brands -- in the alternate site market, where it will sell the products alongside its Kangaroo pumps and Dobbhoff and Entriflex enteral access devices. The two companies will "cooperatively market" their products in the acute care market. Mead Johnson will continue to independently sell its products in the retail consumer market...

You may also be interested in...

Everlywell Raises $175M To Expand Consumer Lab Testing, Digital Health

The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.

UK Faces Distribution Challenges With Pfizer/BioNTech Vaccine

New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.

Global Pharma Guidance Tracker – November 2020

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts